QURE Uniqure Nv

uniQure NV is engaged in the field of gene therapy platform across three therapeutic focus areas: Liver/Metabolic Disease, Central Nervous System (CNS) Disease and Cardiovascular Disease.

$26.30  -0.16 (-0.61%)
As of 12/01/2022 15:59:57 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  The Netherlands
Country of incorporation:  The Netherlands
IPO date:  02/05/2014
Outstanding shares:  46,815,109
Average volume:  877,193
Market cap:   $1,202,680,150
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BJFSR88
Valuation   (See tab for details)
PE ratio:   3.82
PB ratio:   2.26
PS ratio:   2.29
Return on equity:   59.43%
Net income %:   61.76%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy